BioSig Technologies Inc (NASDAQ:BSGM) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Tuesday.

According to Zacks, “BioSig Technologies, Inc. is a medical device company which is engaged in developing technology platform to improve cardiac recording during electrophysiology studies and ablation procedures. BioSig Technologies, Inc. is headquartered in Minnesota. “

Shares of BioSig Technologies (NASDAQ:BSGM) opened at 1.40 on Tuesday. The company has a 50-day moving average of $1.40 and a 200 day moving average of $1.51. The firm’s market cap is $28.67 million. BioSig Technologies has a one year low of $0.90 and a one year high of $2.20.

BioSig Technologies Company Profile

BioSig Technologies, Inc is a development-stage medical device company. The Company is developing a technology platform to manage noise and artifacts from cardiac recordings during electrophysiology studies and ablation. It is engaged in developing the Precise Uninterrupted Real-time evaluation of Electrograms (PURE) electro-pneumatic (EP) System.

5 Day Chart for NASDAQ:BSGM

Get a free copy of the Zacks research report on BioSig Technologies (BSGM)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for BioSig Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies Inc and related companies with's FREE daily email newsletter.